China's doctors and patients love antibiotics. Although the country’s consumption of pharma products remains low, its antibiotic use is disproportionately high. Unfortunately, there is a price for heavy use of antibiotics: the PRC has high levels of drug-resistant infections, especially in tuberculosis and urinary tract infections. In an attempt to stop this trend, China's government is trying to curb overuse of antibiotics, which is having a negative effect on the stock prices of  pharmas that make these products. More details....

Share this with colleagues: